Micro Learning: Black Cisgender and Trans Women, HIV Treatment, & PrEP
Resource updated 05/10/2023
Resource updated 05/10/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
RWHAP Technical Assistance Provider updated on 06/11/2024
Blog updated 03/28/2024
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 03/11/2024
From the HRSA HIV/AIDS Bureau Listserv, 12/16/22
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
We conducted semi-structured interviews with service providers to investigate current barriers, potential opportunities, estimated costs, and anticipated outcomes of program expansion for food, financial, transportation, and housing support services for RWHAP clients.
Resource (Conference Presentation) updated 09/14/2023
We used a data-driven, mixed method approach to develop a community planning and budget tool to inform resource allocation decision-making to achieve health equity in HIV outcomes among RWHAP clients in the Minneapolis-St. Paul Transitional Grant Area.
Resource (Conference Presentation) updated 09/14/2023
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
The COVID-19 public health emergency (PHE) exacerbated homelessness and housing instability. NY EMA Planning staff worked collaboratively to address homelessness as a driving force of poorer health outcomes for people living with HIV. This presentation will illustrate community planning processes for addressing housing-related barriers among RWHAP consumers during the PHE.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Listening Session on how Policy Clarification Notice 16-02 and how the HRSA HAB RWHAP service categories and allowable uses of funds can be refreshed to best reflect new and emerging needs, science, and service delivery models.
Resource (Conference Presentation) updated 09/14/2023